Anwen Yin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anwen Yin has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Ben He
Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China
2 shared publications - Linghong Shen
Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
2 shared publications - Ru-Xing Wang
Department of Cardiology, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, China
2 shared publications - Ruosen Yuan
Department of Cardiovascular Medicine, Rui Jin Hospital (S.C., K.H., Z.-M.W., F.-F.L., Y.M., X.-L.W., J.-M.L., X.-R.W., Q.-J.C., Y.S., X.-Q.W., R.-S.Y., W.-J.L., L.L., Y.D., F.-H.D.), Shanghai Jiao Tong University School of Medicine, P.R. China
2 shared publications - Ben He
Department of Cardiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
1 shared publication Bin Zhou
Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China
1 shared publication
Latest Publications
- Open Access
- 12 August 2024
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 25 (8) , 285
The Role and Underlying Mechanisms of Exercise in Heart Failure
Heart failure is a prevalent and life-threatening syndrome characterized by structural and/or functional abnormalities of the heart. As a global burden with high rates of morbidity and mortality, there is growing recognition of the beneficial effects of exercise on physical fitness and cardiovascular health. A substantial body of evidence supports the notion that exercise can play a protective role in the development and progression of heart failure and improve cardiac function through various mechanisms, such as attenuating cardiac fibrosis, reducing inflammation, and regulating mitochondrial metabolism. Further investigation into the role and underlying mechanisms of exercise in heart failure may uncover novel therapeutic targets for the prevention and treatment of heart failure.
- 12 August 2024
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 25 (8) , 285
Open AccessThe Role and Underlying Mechanisms of Exercise in Heart Failure
Heart failure is a prevalent and life-threatening syndrome characterized by structural and/or functional abnormalities of the heart. As a global burden with high rates of morbidity and mortality, there is growing recognition of the beneficial effects of exercise on physical fitness and cardiovascular health. A substantial body of evidence supports the notion that exercise can play a protective role in the development and progression of heart failure and improve cardiac function through various mechanisms, such as attenuating cardiac fibrosis, reducing inflammation, and regulating mitochondrial metabolism. Further investigation into the role and underlying mechanisms of exercise in heart failure may uncover novel therapeutic targets for the prevention and treatment of heart failure.
- 27 June 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (13) , e23765
TAT ‐beclin1 treatment accelerates the development of atherosclerotic lesions in ApoE ‐deficient mice
The importance of autophagy in atherosclerosis has garnered significant attention regarding the potential applications of autophagy inducers. However, the impact of TAT‐Beclin1, a peptide inducer of autophagy, on the development of atherosclerotic plaques remains unclear. Single‐cell omics analysis indicates a notable reduction in GAPR1 levels within fibroblasts, stromal cells, and macrophages during atherosclerosis. Tat‐beclin1 (T‐B), an autophagy‐inducing peptide derived from Beclin1, could selectively bind to GAPR1, relieving its inhibition on Beclin1 and thereby augmenting autophagosome formation. To investigate its impact on atherosclerosic plaque progression, we established the ApoE −/− mouse model of carotid atherosclerotic plaques. Surprisingly, intravenous administration of Tat‐beclin1 dramatically accelerated the development of carotid artery plaques. Immunofluorescence analysis suggested that macrophage aggregation and autophagosome formation within atherosclerotic plaques were significantly increased upon T‐B treatment. However, immunofluorescence and transmission electron microscopy (TEM) analysis revealed a reduction in autophagy flux through lysosomes. In vitro, the interaction between T‐B and GAPR1 was confirmed in RAW264.7 cells, resulting in the increased accumulation of p62/SQSTM1 and LC3‐II in the presence of ox‐LDL. Additionally, T‐B treatment elevated the protein levels of p62/SQSTM1, LC3‐II, and cleaved caspase 1, along with the secretion of IL‐1β in response to ox‐LDL exposure. In summary, our study underscores that T‐B treatment amplifies abnormal autophagy and inflammation, consequently exacerbating atherosclerotic plaque development in ApoE−/− mice.
- 27 June 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (13) , e23765
TAT ‐beclin1 treatment accelerates the development of atherosclerotic lesions in ApoE ‐deficient mice
The importance of autophagy in atherosclerosis has garnered significant attention regarding the potential applications of autophagy inducers. However, the impact of TAT‐Beclin1, a peptide inducer of autophagy, on the development of atherosclerotic plaques remains unclear. Single‐cell omics analysis indicates a notable reduction in GAPR1 levels within fibroblasts, stromal cells, and macrophages during atherosclerosis. Tat‐beclin1 (T‐B), an autophagy‐inducing peptide derived from Beclin1, could selectively bind to GAPR1, relieving its inhibition on Beclin1 and thereby augmenting autophagosome formation. To investigate its impact on atherosclerosic plaque progression, we established the ApoE −/− mouse model of carotid atherosclerotic plaques. Surprisingly, intravenous administration of Tat‐beclin1 dramatically accelerated the development of carotid artery plaques. Immunofluorescence analysis suggested that macrophage aggregation and autophagosome formation within atherosclerotic plaques were significantly increased upon T‐B treatment. However, immunofluorescence and transmission electron microscopy (TEM) analysis revealed a reduction in autophagy flux through lysosomes. In vitro, the interaction between T‐B and GAPR1 was confirmed in RAW264.7 cells, resulting in the increased accumulation of p62/SQSTM1 and LC3‐II in the presence of ox‐LDL. Additionally, T‐B treatment elevated the protein levels of p62/SQSTM1, LC3‐II, and cleaved caspase 1, along with the secretion of IL‐1β in response to ox‐LDL exposure. In summary, our study underscores that T‐B treatment amplifies abnormal autophagy and inflammation, consequently exacerbating atherosclerotic plaque development in ApoE−/− mice.
- Open Access
- 15 July 2022
- Published by Elsevier in EBioMedicine
- Vol. 82, 104164
Exercise-derived peptide protects against pathological cardiac remodeling
- 15 July 2022
- Published by Elsevier in EBioMedicine
- Vol. 82, 104164
Open AccessExercise-derived peptide protects against pathological cardiac remodeling
- Open Access
- 1 January 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 2017815
Nur77 Deficiency Exacerbates Macrophage NLRP3 Inflammasome‐Mediated Inflammation and Accelerates Atherosclerosis
Purpose. Activation of NLR (nucleotide‐binding and leucine‐rich repeat immune receptor) family pyrin domain containing 3 (NLRP3) inflammasome mediating interleukin‐ (IL‐) 1β secretion has emerged as an important component of inflammatory processes in atherogenesis. The nuclear receptor Nur77 is highly expressed in human atherosclerotic lesions; however, its functional role in macrophage NLRP3 inflammasome activation has not yet been clarified. Methods, Materials, and Results. Eight‐week‐old apolipoprotein E (ApoE)−/− and ApoE−/− Nur77−/− mice that were fed a Western diet underwent partial ligation of the left common carotid artery (LCCA) and left renal artery (LRA) to induce atherogenesis. Four weeks later, severe plaque burden associated with increased lipid deposition, reduced smooth muscle cells, macrophage infiltration, and decreased collagen expression was identified in ApoE−/− Nur77−/− mice compared with those in ApoE−/− mice. ApoE−/− Nur77−/− mice showed increased macrophage inflammatory responses in carotid atherosclerotic lesions. In vitro studies demonstrated that oxidized low‐density lipoprotein cholesterol (ox‐LDL) increased the release of lactate dehydrogenase (LDH) and upregulated the expressions of cleaved caspase‐1, cleaved IL‐1β and gasdermin D (GSMD) in WT peritoneal macrophages (PMs) in a NLRP3‐dependent manner. Nur77−/− PMs exhibited a further increased level of NLRP3 inflammasome‐mediated inflammation under ox‐LDL treatment compared with WT PMs. Mechanistically, Nur77 could bind to the promoter of NLRP3 and inhibit its transcriptional activity. Conclusions. This study demonstrated that Nur77 deletion promotes atherogenesis by exacerbating NLRP3 inflammasome‐mediated inflammation.
- 1 January 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 2017815
Open AccessNur77 Deficiency Exacerbates Macrophage NLRP3 Inflammasome‐Mediated Inflammation and Accelerates Atherosclerosis
Purpose. Activation of NLR (nucleotide‐binding and leucine‐rich repeat immune receptor) family pyrin domain containing 3 (NLRP3) inflammasome mediating interleukin‐ (IL‐) 1β secretion has emerged as an important component of inflammatory processes in atherogenesis. The nuclear receptor Nur77 is highly expressed in human atherosclerotic lesions; however, its functional role in macrophage NLRP3 inflammasome activation has not yet been clarified. Methods, Materials, and Results. Eight‐week‐old apolipoprotein E (ApoE)−/− and ApoE−/− Nur77−/− mice that were fed a Western diet underwent partial ligation of the left common carotid artery (LCCA) and left renal artery (LRA) to induce atherogenesis. Four weeks later, severe plaque burden associated with increased lipid deposition, reduced smooth muscle cells, macrophage infiltration, and decreased collagen expression was identified in ApoE−/− Nur77−/− mice compared with those in ApoE−/− mice. ApoE−/− Nur77−/− mice showed increased macrophage inflammatory responses in carotid atherosclerotic lesions. In vitro studies demonstrated that oxidized low‐density lipoprotein cholesterol (ox‐LDL) increased the release of lactate dehydrogenase (LDH) and upregulated the expressions of cleaved caspase‐1, cleaved IL‐1β and gasdermin D (GSMD) in WT peritoneal macrophages (PMs) in a NLRP3‐dependent manner. Nur77−/− PMs exhibited a further increased level of NLRP3 inflammasome‐mediated inflammation under ox‐LDL treatment compared with WT PMs. Mechanistically, Nur77 could bind to the promoter of NLRP3 and inhibit its transcriptional activity. Conclusions. This study demonstrated that Nur77 deletion promotes atherogenesis by exacerbating NLRP3 inflammasome‐mediated inflammation.